To lead a sustainable energy future, the European Commission and the European Investment Bank have announced an investment of €3.66 billion from the EU’s Modernisation Fund.
Bengt Fellbe, Program Leader, SSEC, Swedish Surplus Energy Collaboration, explains how sustainable food production is not just about circular production models, there are more important links in the food system.
Paul Wash, Founder and Managing Director of digital transformation specialists Zenaxys, discusses how and why the UK should utilise SME’s to advance digital strategy.
One consequence of the pandemic is that embracing ‘social value’ as a way of supporting our communities has grown stronger - Guy Battle, CEO of the Social Value Portal, discusses the importance of becoming Social Value Creators.
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.
What does it take for humans and elephants to live together? This was the question that has guided nearly 18 years of research and local engagement in the Gourma region of central Mali.
AXIS Research Programme Coordinator Rolf von Kuhlmann explains why connecting scientific disciplines with society is crucial for climate change policy.
From 2022, Horizon Europe funding applications by public bodies, research organisations and higher education institutions will only be considered if they have a gender equality plan.
Over the weekend, the Republic of Ireland suspended their use of AstraZeneca due to reports of blood clots in Norway - in response, the European Medicines Agency (EMA) says the AstraZeneca vaccine is still safe to use.
Tim Kiely, Criminal Barrister at Red Lion Chambers, discusses the #CurfewForMen as a wake-up call on societal acceptance of "violent male behaviour toward women".
SDG Group is a global data and analytics consulting firm, offering in-depth expertise that empowers its clients’ strategies to become data-driven enterprises and bridges the gap between data and business decisions.
Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.
There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.
The US based vaccine appears to be 96.4% effective against the original COVID mutation, with 86% efficacy against the UK variant and only 55% against the South African variant.
The 'London patient' joins the 'Berlin patient' as the second person in history to be cured of HIV, which is achieved via transplant of rare HIV-resistant stem cells.
Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.
